Literature DB >> 27796859

Anxiety and Cardiovascular Disease Risk: a Review.

Phillip J Tully1,2,3, Nathan J Harrison4,5, Peter Cheung5, Suzanne Cosh6.   

Abstract

Unrecognized anxiety is a difficult clinical presentation in cardiology. Anxiety leads to recurring emergency department visits and the need for numerous diagnostic evaluations to rule out cardiovascular disease (CVD). This review focuses broadly on anxiety and its subtypes in relation to the onset and progression of CVD while describing helpful guidelines to better identify and treat anxiety. Potential mechanisms of cardiopathogenesis are also described. An emerging literature demonstrates that anxiety disorders increase the risk for incident CVD but a causal relationship has not been demonstrated. Anxiety portends adverse prognosis in persons with established CVD that is independent from depression. The level of clinical priority received by depression should be extended to research and clinical intervention efforts in anxiety. Anxiety holds direct relevance for uncovering mechanisms of cardiopathogenesis, developing novel therapeutic strategies, and initiating clinical interventions in the population at risk of developing heart disease, or those already diagnosed with CVD.

Entities:  

Keywords:  Anxiety disorders; Cardiovascular disease; Review; Risk factor

Mesh:

Year:  2016        PMID: 27796859     DOI: 10.1007/s11886-016-0800-3

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  75 in total

1.  Myocardial infarction and generalised anxiety disorder: 10-year follow-up.

Authors:  Annelieke M Roest; Marij Zuidersma; Peter de Jonge
Journal:  Br J Psychiatry       Date:  2012-03-08       Impact factor: 9.319

2.  Anxiety and risk of incident coronary heart disease: a meta-analysis.

Authors:  Annelieke M Roest; Elisabeth J Martens; Peter de Jonge; Johan Denollet
Journal:  J Am Coll Cardiol       Date:  2010-06-29       Impact factor: 24.094

3.  Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction.

Authors:  Jeffrey F Scherrer; Timothy Chrusciel; Lauren D Garfield; Kenneth E Freedland; Robert M Carney; Paul J Hauptman; Kathleen K Bucholz; Richard Owen; Patrick J Lustman
Journal:  Br J Psychiatry       Date:  2012-01-12       Impact factor: 9.319

4.  Association of anxiety disorders and depression with incident heart failure.

Authors:  Lauren D Garfield; Jeffrey F Scherrer; Paul J Hauptman; Kenneth E Freedland; Tim Chrusciel; Sumitra Balasubramanian; Robert M Carney; John W Newcomer; Richard Owen; Kathleen K Bucholz; Patrick J Lustman
Journal:  Psychosom Med       Date:  2014-01-16       Impact factor: 4.312

5.  Risk of incident cardiovascular events amongst individuals with anxiety and depression: A prospective cohort study in the east London primary care database.

Authors:  R Mathur; M Pérez-Pinar; Q Foguet-Boreu; S Ayis; L Ayerbe
Journal:  J Affect Disord       Date:  2016-07-19       Impact factor: 4.839

6.  Neurocirculatory asthenia, anxiety and neurosis.

Authors:  H H W MILES; S COBB
Journal:  N Engl J Med       Date:  1951-11-08       Impact factor: 91.245

7.  Coronary artery disease in association with depression or anxiety among patients undergoing angiography to investigate chest pain.

Authors:  Mutlu Vural; Omer Satiroglu; Berfu Akbas; Isin Goksel; Ocal Karabay
Journal:  Tex Heart Inst J       Date:  2009

8.  Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment.

Authors:  Gregory M Sullivan; Justine M Kent; Marc Kleber; Jose M Martinez; Vikram K Yeragani; Jack M Gorman
Journal:  Psychiatry Res       Date:  2004-01-30       Impact factor: 3.222

9.  Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression.

Authors:  Naomi M Simon; Jordan W Smoller; Maurizio Fava; Gary Sachs; Stephanie R Racette; Roy Perlis; Shamsah Sonawalla; Jerrold F Rosenbaum
Journal:  J Psychiatr Res       Date:  2003 May-Jun       Impact factor: 4.791

10.  The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models.

Authors:  B T Baune; M Stuart; A Gilmour; H Wersching; W Heindel; V Arolt; K Berger
Journal:  Transl Psychiatry       Date:  2012-03-13       Impact factor: 6.222

View more
  27 in total

1.  Pharmacological Management of Anxiety Disorders in the Elderly.

Authors:  Elizabeth A Crocco; Sindy Jaramillo; Caroline Cruz-Ortiz; Katherine Camfield
Journal:  Curr Treat Options Psychiatry       Date:  2017-02-10

Review 2.  Childhood and Adolescent Adversity and Cardiometabolic Outcomes: A Scientific Statement From the American Heart Association.

Authors:  Shakira F Suglia; Karestan C Koenen; Renée Boynton-Jarrett; Paul S Chan; Cari J Clark; Andrea Danese; Myles S Faith; Benjamin I Goldstein; Laura L Hayman; Carmen R Isasi; Charlotte A Pratt; Natalie Slopen; Jennifer A Sumner; Aslan Turer; Christy B Turer; Justin P Zachariah
Journal:  Circulation       Date:  2017-12-18       Impact factor: 29.690

3.  Attention-deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population-based cohort study.

Authors:  Lin Li; Zheng Chang; Jiangwei Sun; Miguel Garcia-Argibay; Ebba Du Rietz; Maja Dobrosavljevic; Isabell Brikell; Tomas Jernberg; Marco Solmi; Samuele Cortese; Henrik Larsson
Journal:  World Psychiatry       Date:  2022-10       Impact factor: 79.683

4.  Anxiety as a risk factor for cardiovascular disease independent of depression: a prospective examination of community-dwelling men (the MrOS study).

Authors:  Håvard R Karlsen; Ingvild Saksvik-Lehouillier; Katie L Stone; Eva Schernhammer; Kristine Yaffe; Eva Langvik
Journal:  Psychol Health       Date:  2020-06-25

5.  A Comparison of Sugar Intake between Individuals with High and Low Trait Anxiety: Results from the NutriNet-Santé Study.

Authors:  Junko Kose; Adrienne Cheung; Léopold K Fezeu; Sandrine Péneau; Charlotte Debras; Mathilde Touvier; Serge Hercberg; Pilar Galan; Valentina A Andreeva
Journal:  Nutrients       Date:  2021-04-30       Impact factor: 5.717

6.  Comparison of the Effects of Religious Cognitive Behavioral Therapy (RCBT), Cognitive Behavioral Therapy (CBT), and Sertraline on Depression and Anxiety in Patients after Coronary Artery Bypass Graft Surgery: Study Protocol for a Randomized Controlled Trial.

Authors:  Seyed Hamzeh Hosseini; Alireza Rafiei; Ali Gaemian; Abdolhakim Tirgari; Aliasghar Zakavi; Jamshid Yazdani; Jafar Bolhari; Mahmood Golzari; Zahra Esmaeili Douki; Nazanin Vaezzadeh
Journal:  Iran J Psychiatry       Date:  2017-07

7.  Cardiac Rehabilitation Patients' Accounts of Their Emotional Distress and Psychological Needs: A Qualitative Study.

Authors:  Rebecca McPhillips; Peter Salmon; Adrian Wells; Peter Fisher
Journal:  J Am Heart Assoc       Date:  2019-06-01       Impact factor: 5.501

8.  Anxiety disturbs the blood plasma metabolome in acute coronary syndrome patients.

Authors:  HongYan Wei; JunYuan Gu; XueYao Jiang; Nan Deng; Jing Wu; LianHong Zou; YiMin Zhu; BoYu Tan
Journal:  Sci Rep       Date:  2021-06-18       Impact factor: 4.379

Review 9.  QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.

Authors:  Anhua Wei; Jinlan Peng; Zhichun Gu; Juan Li
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

10.  A functional genetic variation of SLC6A2 repressor hsa-miR-579-3p upregulates sympathetic noradrenergic processes of fear and anxiety.

Authors:  L G Hommers; J Richter; Y Yang; A Raab; C Baumann; K Lang; M A Schiele; H Weber; A Wittmann; C Wolf; G W Alpers; V Arolt; K Domschke; L Fehm; T Fydrich; A Gerlach; A T Gloster; A O Hamm; S Helbig-Lang; T Kircher; T Lang; C A Pané-Farré; P Pauli; B Pfleiderer; A Reif; M Romanos; B Straube; A Ströhle; H-U Wittchen; S Frantz; G Ertl; M J Lohse; U Lueken; J Deckert
Journal:  Transl Psychiatry       Date:  2018-10-19       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.